Observational Study
Copyright ©The Author(s) 2020.
World J Hepatol. Oct 27, 2020; 12(10): 850-862
Published online Oct 27, 2020. doi: 10.4254/wjh.v12.i10.850
Table 3 Discriminating ability of the novel markers in the studied groups
Variable
VLDL

CIMT

LDL/platelet ratio

ABI

Cutoff value
Below 16.5
Above 16.5
P value
Below 1.1
Above 1.1
P value
Below 1
Above 1
P value
Below 0.94
Above 0.94
P value
n76164-96144-98142-70170-
Sex (M/F)56/20106/580.264/3298/460.8666/3296/460.8347/23115/550.45
Age (yr)50.3 ± 1048.5 ± 8.30.349.6 ± 8.648.7 ± 90.5649.8 ± 8.848 ± 90.7851.5 ± 8.948.2 ± 7.40.2
AST (IU/L)46 ± 11.638.4 ± 12.10.0147.5 ± 11.834.9 ± 8.40.0152 ± 1135 ± 90.00149 ± 1238 ± 110.03
ALT (IU/L)45 ± 8.437.5 ± 8.50.0346 ± 835.4 ± 70.0345 ± 7.834 ± 5.60.0243 ± 832 ± 80.047
Platelet count × 10383.6 ± 47165.5 ± 62.20.00182.5 ± 41.4182 ± 400.00181 ± 26188 ± 410.00187 ± 23160 ± 610.001
Total cholesterol166 ± 21198 ± 240.02170 ± 18200.5 ± 260.034168 ± 26197 ± 280.04173 ± 27196 ± 250.023
Triglycerides (mg/dL)135.7 ± 15164 ± 190.03137 ± 15168 ± 150.032140 ± 19168 ± 160.045143 ± 18162 ± 240.01
VLDL (mg/dL)14.6 ± 1.526.2 ± 5.60.00117 ± 4.928 ± 70.00115 ± 432 ± 60.00117 ± 525 ± 120.03
LDL (mg/dL)106 ± 15126 ± 210.001102 ± 13130 ± 200.023110 ± 17122 ± 200.06109 ± 19129 ± 220.021
HDL (mg/dL)40 ± 443 ± 80.8939 ± 542 ± 8.20.4540 ± 542 ± 80.8239 ± 442 ± 80.34
FIB-45.03 ± 1.82.2 ± 1.60.0015 ± 21.7 ± 0.60.0014.9 ± 1.91.6 ± 0.50.0014.2 ± 22.4 ± 1.90.01
LDL/platelet count ratio1.5 ± 0.480.84 ± 0.30.0011.4 ± 0.40.75 ± 0.210.0011.5 ± 0.30.7 ± 0.150.0011.24 ± 0.210.91 ± 0.340.001S
Splenic diameter (mm)186.3 ± 25.4141.5 ± 240.001185.4 ± 20133 ± 170.001181 ± 24122 ± 110.001171 ± 29136 ± 130.001
Platelets/SD492.6 ± 76.21237.7 ± 5020.001463.3 ± 431400 ± 4100.001471 ± 2131440 ± 4020.001678 ± 2981173 ± 5540.001